All lobbying filings

Novo Nordisk Inc.

Novo Nordisk Inc. filed a Q1 report for Novo Nordisk Inc. on April 18, 2025.

Lobbying for Novo Nordisk Inc.

As filed: NOVO NORDISK INC. for NOVO NORDISK INC.

All filings by Novo Nordisk Inc. · Everything Novo Nordisk Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Expenses

$2,330,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 3

BRIAN BRANTON

Previously held: Chief of Staff, Congressman Jared Polis
ANSLEY RHYNE

Previously held: Legislative Assistant, Senator Marco Rubio
CHAD YELINSKI New on this filing

Previously held: Deputy Chief of Staff, Senator Ted Budd

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act, General Compounding

Budget/Appropriations

Labor-HHS Appropriations Bill, Military Construction, Treat and Reduce Obesity Act, General Compounding

Medicare/Medicaid

Obesity, Treat and Reduce Obesity Act, IRA implementation

S. 150, Affordable Prescriptions for Patients Act, Patent Protection, General IP Issues, General Compounding

Bills named in this filing 1

S. 150
Affordable Prescriptions for Patients Act of 2023

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.